Pediatrics – Adolescent Medicine
WHO Pocket book of primary health care for children and adolescents.
1 Dec, 2022 | 14:09h | UTC
WHO updates recommendations to guide family planning decisions.
24 Nov, 2022 | 13:38h | UTCNews Release: WHO updates recommendations to guide family planning decisions – World Health Organization
Family planning: A global handbook for providers – World Health Organization (PDF)
Commentary on Twitter (thread – click for more)
👉WHO releases important updates to its Family Planning Handbook 🔖
⏭providing health workers and policymakers with the most updated information on contraceptive options.
Know more:🔗https://t.co/UhC1BFca2r pic.twitter.com/LQEtm3wmbZ
— World Health Organization (WHO) (@WHO) November 15, 2022
RCT | Once-weekly Semaglutide effective for weight loss in adolescents with obesity.
4 Nov, 2022 | 13:59h | UTCOnce-Weekly Semaglutide in Adolescents with Obesity – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries:
STEP TEENS: High-dose semaglutide weight loss benefits shown in adolescents – medwire News
Trial Shows Weight-Loss Drug Works in Teens – HealthDay
Commentary on Twitter
In this trial, adolescents with obesity assigned to weekly subcutaneous semaglutide plus lifestyle intervention had a greater reduction in BMI than those who received lifestyle intervention alone. https://t.co/yiFseP38xa pic.twitter.com/uRqkFfon1s
— NEJM (@NEJM) November 2, 2022
Cross-Sectional Study | Prevalence of and factors associated with high blood pressure among adolescents in India.
3 Nov, 2022 | 13:57h | UTCInvited Commentary: Prevalence of High Blood Pressure Among Youth in India and Association With Future Cardiovascular Disease – JAMA Network Open
Commentary on Twitter
1 in 3 adolescents in India have high BP, which is is associated with the trifecta of overweight/obesity, high blood sugar, high blood lipids, and can be prevented. #OAResearch https://t.co/i2Cth5ol2T
— JAMA Network Open (@JAMANetworkOpen) October 31, 2022
RCT | Impact of vaping prevention advertisements on adolescents.
14 Oct, 2022 | 13:57h | UTCNews Release: Researchers find FDA ‘Real Cost’ ads reduce teen openness to vaping – UNC Lineberger Comprehensive Cancer Center
Commentary on Twitter
RCT: Real Cost vaping prevention ads led to lower youth susceptibility to vaping and discouraged cigarette smoking. #OAReaserch https://t.co/ASl5oXbn5Z pic.twitter.com/9Uaj4zc7sK
— JAMA Network Open (@JAMANetworkOpen) October 13, 2022
Psychological violence in dating relationships among adolescents | A systematic review and meta-analysis of prevention programs.
21 Jul, 2022 | 12:47h | UTC
FDA orders Juul to remove all its e-cigarettes from US market.
6 Jul, 2022 | 11:46h | UTCFDA orders Juul to remove all its e-cigarettes from US market – The BMJ
See also:
FDA orders all Juul e-cigarettes off the market – POLITICO
The FDA orders Juul to pull all of its vaping products from the U.S. market – NPR
FDA orders Juul Labs to remove products from US market – CNN
FDA News Release: FDA Denies Authorization to Market JUUL Products – U.S. Food & Drug Administration
Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019.
30 Jun, 2022 | 11:28h | UTC
Commentaries on Twitter
(Thread – click for more)
NEW—#GBDstudy Improving road safety measures (helmets, seatbelts, obeying speed limits, and avoiding drunk driving) could save half a million lives every year WORLDWIDE. @TheLancet @LancetPH #RoadSafety#InvestInYouthhttps://t.co/E2RdjazHDF
— Institute for Health Metrics and Evaluation (IHME) (@IHME_UW) June 30, 2022
(Thread – click for more)
Our new research published in @TheLancetPH “highlights the neglect and chronic underinvestment by the global health community to prevent injury-related harms in adolescents.” @UNSW @UNSWMedicine @CforAH @MCRI_for_kids @IHME_UW @georgeinstitute https://t.co/gjbndubxGE
— Dr Amy Peden (@amyepeden) June 29, 2022
AHA Scientific Statement: Cardiopulmonary consequences of vaping in adolescents.
23 Jun, 2022 | 13:03h | UTCNews Release: Action needed to reduce e-cigarette use among adolescents to lower lifetime CVD risk – American Heart Association
M-A: Overweight/obesity in childhood and the risk of early puberty.
21 Jun, 2022 | 10:36h | UTCRelated Study: Patterns of Early Life Weight Gain and Female Onset of Puberty – Journal of the Endocrine Society
NICE Guideline: Reducing sexually transmitted infections.
16 Jun, 2022 | 11:15h | UTCReducing sexually transmitted infections – National Institute for Health and Care Excellence
Systematic review: educational interventions to improve the menstrual health of young adolescent girls.
10 Jun, 2022 | 10:59h | UTC
#ADA2022 – RCT: Once-weekly dulaglutide for the treatment of youths with type 2 diabetes.
6 Jun, 2022 | 11:57h | UTCOnce-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Once Weekly Drug Helps Control Pediatric Type 2 Diabetes – American Diabetes Association
Commentary on Twitter
Trial compared once-weekly dulaglutide with placebo for glycemic control in youths with type 2 diabetes who may have been receiving metformin or basal insulin. Dulaglutide was superior at 26 weeks. #ADA2022 https://t.co/P6PubXvHOR pic.twitter.com/1JPIT5IyTe
— NEJM (@NEJM) June 4, 2022
M-A: Screen time and body mass index among children and adolescents.
3 Jun, 2022 | 11:44h | UTCRelated:
M-A: Global prevalence of meeting screen time guidelines among children 5 years and younger.
Media and Young Minds – American Academy of Pediatrics
AAP Policy Statement: Recommended terminology for substance use disorders in the care of children, adolescents, young adults, and families.
2 Jun, 2022 | 11:00h | UTC
Commentary from one of the authors on Twitter (thread – click for more)
1/New @AmerAcadPeds policy statement led by @DrRachelAlinsky with @jquigleymd @DrScottHadland – Terminology for Substance Use Disorders in the Care of Children, Adolescents, Young Adults, and Families.
I'm proud to be a part & there's a cool backstory!https://t.co/CkxtS9BYxN
— Stephen Patrick, MD, MPH (@stephenwpatrick) May 25, 2022
Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta‐analysis.
1 Jun, 2022 | 11:09h | UTC
Commentary on Twitter (thread – click for more)
1) Hot off the press!
"Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta‐analysis"#Evidence suggests levonorgestrel‐releasing intrauterine system (LNG‐IUS) is the best first‐line treatment for reducing menstrual blood loss;
— Cochrane Gynaecology & Fertility (@CochraneCGF) May 31, 2022
M-A: Effectiveness and harms of contraceptive counseling and provision interventions for women.
26 May, 2022 | 10:23h | UTCEffectiveness and Harms of Contraceptive Counseling and Provision Interventions for Women: A Systematic Review and Meta-analysis – Annals of Internal Medicine (link to abstract – $ for full-text)
Annals Video Summary: Effectiveness and Harms of Contraceptive Counseling and Provision Interventions for Women: A Systematic Review and Meta-analysis
Commentary: Contraceptive counseling, provision increases use, reduces unintended pregnancy – ACP Internist
AHA Scientific Statement: Ambulatory blood pressure monitoring in children and adolescents.
24 May, 2022 | 10:47h | UTCNews Release: Statement updates ambulatory blood pressure classification in children and adolescents – American Heart Association
M-A: Interventions to improve immunization coverage among children and adolescents.
11 May, 2022 | 10:45h | UTC
Systematic Review: Preventing unintentional injuries in school-aged children.
9 May, 2022 | 01:13h | UTCPreventing Unintentional Injuries in School-Aged Children: A Systematic Review – Pediatrics
Systematic Review: Interventions to promote physical activity and healthy digital media use in children and adolescents.
9 May, 2022 | 01:10h | UTC
M-A: Interventions for high-burden infectious diseases in children and adolescents.
9 May, 2022 | 01:12h | UTC
Interventions for health and well-being in school-aged children and adolescents: a way forward.
9 May, 2022 | 01:09h | UTC
RCT: Phentermine/Topiramate for the treatment of adolescent obesity.
2 May, 2022 | 00:41h | UTCPhentermine/Topiramate for the Treatment of Adolescent Obesity – NEJM Evidence
Commentary on Twitter
This RCT evaluated phentermine/topiramate in adolescents ages 12 to <17 yrs with high BMIs over a 56 week period. At both mid- and top-doses, treatment significantly reduced BMI and waist circumference compared to placebo. https://t.co/HbCZOAlZPf@PedsEndoSociety #PedsEndo2022 pic.twitter.com/nB5juqxyA0
— NEJM Evidence (@NEJMEvidence) April 30, 2022
The Lancet Series: Optimizing child and adolescent health and development.
29 Apr, 2022 | 10:55h | UTCHomepage: Optimising Child and Adolescent Health and Development – The Lancet (free registration required for all articles)
Health and development from preconception to 20 years of age and human capital
Optimising child and adolescent health and development in the post-pandemic world
Opportunities in crisis for optimising child health and development